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ABSTRACT: The rate and extent of drug dissolution and absorption from
solid oral dosage forms is highly dependent on the volume of liquid in the
gastrointestinal tract (GIT). However, little is known about the time course of
GIT liquid volumes after drinking a glass of water (8 oz), particularly in the
colon, which is a targeted site for both locally and systemically acting drug
products. Previous magnetic resonance imaging (MRI) studies oﬀered novel
insights on GIT liquid distribution in fasted humans in the stomach and small
intestine, and showed that freely mobile liquid in the intestine collects in fairly
distinct regions or “pockets”. Based on this previous pilot data, we
hypothesized that (1) it is possible to quantify the time course of the volume
and number of liquid pockets in the undisturbed colon of fasted healthy humans following ingestion of 240 mL, using
noninvasive MRI methods; (2) the amount of freely mobile water in the fasted human colon is of the order of only a few
milliliters. Twelve healthy volunteers fasted overnight and underwent fasted abdominal MRI scans before drinking 240 mL (∼8
ﬂuid ounces) of water. After ingesting the water they were scanned at frequent intervals for 2 h. The images were processed to
quantify freely mobile water in the total and regional colon: ascending, transverse, and descending. The fasted colon contained
(mean ± SEM) 11 ± 5 pockets of resting liquid with a total volume of 2 ± 1 mL (average). The colonic ﬂuid peaked at 7 ± 4 mL
30 min after the water drink. This peak ﬂuid was distributed in 17 ± 7 separate liquid pockets in the colon. The regional analysis
showed that pockets of free ﬂuid were found primarily in the ascending colon. The interindividual variability was very high; the
subjects showed a range of number of colonic ﬂuid pockets from 0 to 89 and total colonic freely mobile ﬂuid volume from 0 to
49 mL. This is the ﬁrst study measuring the time course of the number, regional location, and volume of pockets of freely mobile
liquid in the undisturbed colon of fasted humans after ingestion of a glass of water. Novel insights into the colonic ﬂuid
environment will be particularly relevant to improve our understanding and design of the in vivo performance of controlled
release formulations targeted to the colon. The in vivo quantitative information presented here can be input into physiologically
based mechanistic models of dissolution and absorption, and can be used in the design and set up of novel in vitro performance
tools predictive of the in vivo environment.
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■ INTRODUCTION
The colonic luminal environment is key for the dissolution of
oral drug products speciﬁcally aimed at colonic delivery. Colon-
speciﬁc drug delivery systems (CDDS) have gained momentum
in recent years due to their potential for treatment of local
diseases as well as for exploitation of the colon as a site of
delivery of peptides and proteins, which can degrade in the
gastric and small intestine compartments.1,2 The colon will also
play a role in the dissolution of high dose or low permeability
drugs that may not have been entirely released and absorbed in
the small intestine.3 Together with other important physio-
logical parameters, such as buﬀer species, pH, bile salts, and
pressure (motility), the amount of ﬂuid available will also
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signiﬁcantly inﬂuence the rate and extent of drug release/
dissolution and absorption in the colon and thus bioperform-
ance.
Knowledge of the ﬂuid environment in the upper (stomach
and small intestine) gastrointestinal tract (GIT) has consid-
erably improved over the past decade.4 By contrast, much
remains to be learnt about the colonic (“uncharted waters”5)
environment which has been the subject of only a few studies to
date. The colon is a large organ. The ascending, transverse and
descending colon together contain an average of 561 ± 321 mL
of biomass6 which is 86% water (e.g., 482 ± 266 mL).7
However, most of this water in the colonic chyme is not freely
available (visible) and is either bound or contained inside
bacteria/biomass. Pioneering magnetic resonance imaging
(MRI) work by Schiller and colleagues8 described intestinal
free water as separated in a series of scattered pockets and
showed that, in the undisturbed colon, there is very little freely
mobile, available ﬂuid. Colonic free ﬂuid volumes were
estimated at an average of 13 mL with a range of 1−44 mL.8
Our own previous experience using MRI found 3 mL (range
0−29 mL) in the fasted ascending colon.9
Colonoscopy studies allowed direct collection of ﬂuid
samples from the cecum3 and ascending colon.10 In the
cecum, in the fasted state, 5 mL of material were retrieved. The
aqueous fraction of this chyme was 70%. In the fasted state, in
the ascending colon 22 mL of material were retrieved, of which
again 70% were aqueous fraction. While some of the diﬀerences
between the colonoscopy and MRI values from these studies
may reﬂect sampling diﬃculties and/or image data processing
diﬀerences, overall the available literature seems to be in good
agreement that there is only a very small amount of free liquid
in the colon. Direct collection of colonic ﬂuid samples from
colonoscopy, led to the development of biorelevant11 simulated
colonic ﬂuids.12
Of particular interest is the ﬂuid distribution in fasted
humans after ingestion of a glass of water (∼8 oz). This volume
of water is typical of relative bioavailability (BA) and
bioequivalence (BE) testing in human subjects, to support
drug applications with regulatory agencies.13−16 In our previous
study we investigated the time course, number, volume, and
location of water pockets in the stomach and small intestine
under conditions that represent standard BA/BE studies using
validated techniques. However, there are no such data available
in the literature for the distribution and time course of free
colonic water pockets in the colon.
This study was built on our previous work and was aimed to
characterize the time course of the volume and number of
colonic freely mobile water pockets of fasted healthy subjects,
before and after ingestion of a 240 mL dose of water using
MRI. We predicted that the time course of volume and number
of colon water pockets following a 240 mL dose of water would
reﬂect the low values previously measured, using diﬀerent
protocols.
Such quantitative information on the time course of freely
mobile colonic liquid can be used in conjunction with
knowledge of the volume of entrapped liquid, as well as with
new insights into the properties and composition of colonic
ﬂuid3,10,12,17 to help develop our understanding of solubility
and dissolution of drug products in the fasted colon. When
considered as a whole, these diﬀerent pieces of information can
help strengthen the outputs of physiologically based mecha-
nistic modeling of the gastrointestinal tract and guide design of
in vitro experiments aimed at predicting dosage form
bioperformance.
■ MATERIALS AND METHODS
Study Design. The primary outcome measure was the total
volume of freely mobile water in the colon (mL). Secondary
outcome measures were the number of water pockets in the
colon and their volumes (in mL) as well as their location in the
three regional colon segments divided into ascending, trans-
verse, and descending colon. The exploratory outcome was the
correlation between small and large bowel liquid pockets.
The study design, participants, and data sets used for this
work are from the original MRI study.18 Brieﬂy, the study had a
single-center, one-way, open-label design consisting of a
screening visit and one test day. After an initial fasted baseline
MRI scan, subjects drank 240 mL of water and were scanned at
intervals for up to 2 h post ingestion. Image data was acquired
before the 240 mL water drink and afterward at times 2, 4, 8,
12, 16, 20, 24, 28, 32, 45, 60, 75, 90, 105, and 120 min.
The previous study (ClinicalTrials.gov identiﬁer
NCT01792453) was approved by the local Medical School
Research Ethics Committee and was conducted according to
Good Clinical Practice principles. The Ethics approval included
additional data analysis work that might have arisen and the
volunteers gave written informed consent.
Study Participants. Twelve healthy volunteers took part in
the study. They were 4 male and 8 female, 21.3 ± 0.6 years old
with body mass index of 22.1 ± 0.6 kg/m2. The inclusion
criteria and lifestyle restrictions were designed to be as close as
possible to the US Food and Drug Administration (FDA)
guidelines for the assessment of Fasted Treatments in healthy
volunteers.14 They were asked to fast from 10 pm the evening
prior to the MRI study day. Water was allowed but not after 7
am of the study day, after which the subjects were asked not to
eat or drink anything until arriving at the study site at 8 am.
Magnetic Resonance Imaging. MRI scanning was
performed on a research-dedicated 1.5 T Philips Achieva
MRI scanner (Philips Healthcare, Eindhoven, The Nether-
lands). Volunteers were positioned supine with a 16-element
parallel imaging receiver coil wrapped around their abdomen. A
single shot, fast spin echo sequence (Rapid Acquisition with
Relaxation Enhancement, RARE) acquired in a single breath-
hold 24 coronal images with in-plane resolution interpolated to
0.78 mm × 0.78 mm and a slice thickness of 7 mm, with no gap
between slices (TR = 8000 ms, TE = 320 ms, acquired
resolution = 1.56 mm × 2.90 mm). This sequence yields high
intensity signals from areas with ﬂuid and little signal from body
tissues, and is used to measure small and large intestinal water
content. This image set was acquired on a 24 s expiration
breath-hold, monitored using a respiratory belt.
Data Analysis. The individual values are plotted providing a
full representation of the individual variability. The data are also
shown as time course of the mean ± standard error of the mean
(SEM) for ease of display, although some of the parameters
were not normally distributed. Analyses were carried out using
the Per Protocol (PP) population. The colonic water pockets
and volumes were assessed using a new extension of the in-
house developed program, to determine volumes of freely
mobile small bowel water content.19 The RARE sequence is
strongly T2 weighted hence images mostly freely mobile liquid
(which appears very bright in the images) while the signal from
less mobile liquid and body tissues has decayed (and appears
dark in such images). The analysis software then uses the signal
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distribution of the cerebrospinal ﬂuid, which is freely mobile, to
determine the threshold (cutoﬀ) above which a bright signal in
the image belongs to freely mobile ﬂuid. The exact threshold
point has been determined from a validation intubation study19
whereby known amounts of poorly absorbable ﬂuid were
instilled in the small bowel and measured by MRI. Without this
internal reference and thresholding method the determination
of ﬂuid volumes would be inaccurate. The user graphic interface
is shown in Figure 1.
Separate regions of interest (ROIs) were drawn manually
around the visible regions of the ascending, transverse, and
descending colon on each coronal image slice using in-house
software on an IDL platform (IDL 6.4; Research Systems Inc.,
Boulder, CO, USA). These ROIs excluded regions, such as the
stomach, gall bladder, small bowel, and blood vessels. The
software then identiﬁed (in the 3-dimensional multislice data
set) all signal regions within the colonic ROIs with intensity
above a threshold, determined from the subject’s cerebrospinal
ﬂuid. The sum of all those colonic regions provided the total
colon water content. To deﬁne the colonic free water pockets, a
mask was generated from the large intestinal regions identiﬁed
and a region-growing algorithm was used to determine the size
of each connected region. The software recoded the number of
pockets and their volume. The pockets were categorized by
volume into predeﬁned pocket “bins”. The ﬁrst bin contained
all the smallest water pockets, with volumes ranging from a
single imaging voxel up to <0.5 mL. The other bins
corresponded to the ranges 0.5−2.5, 2.5−5, 5−10, 10−20,
and >20 mL. As the water pockets are derived from the
segmentation of all the colon in the images, it follows that the
sum of all the pockets’ volumes corresponds to the total colon
value at any given time point. For the colon water pocket
analysis all water pockets were included. This is diﬀerent from
the previous small bowel analysis whereby very small water
pockets contributed only to a small percentage of the total
small bowel water volume.
Power and Statistical Analysis. This was a posthoc
analysis hence no power calculation was available. Statistical
analysis was carried out using Prism 5 (GraphPad Software Inc.,
La Jolla, CA). The data were tested for normality using the
Shapiro-Wilk Test. Pearson’s test was used to assess the
correlation between peak colon liquid volumes and lower right
quadrant small bowel liquid volumes. A p-value < 0.05 was
considered to be statistically signiﬁcant.
■ RESULTS
Good quality images were obtained from all subjects and the
software was successfully used to assess the colonic free water
pockets (Figure 2).
Colon Liquid Volume as a Function of Time. This was
the primary outcome of this study. The individual colon freely
mobile liquid volume data as a function of time are shown in
Figure 3A and the corresponding mean data in Figure 3B. The
fasted colon contained a small amount of resting liquid with a
Figure 1. Screenshot of the colonic liquid pockets data analysis software. The operator loads the single shot, fast spin echo sequence (Rapid
Acquisition with Relaxation Enhancement, RARE) images as shown on the left-hand side. In this kind of MRI sequence, freely mobile liquid appears
very bright and less mobile liquid and body tissues appear dark. The operator can draw a speciﬁc region of interest and assign it to a given region (in
this example the ascending colon). The software then locates and measures the liquid pockets whose signal is above a signal threshold for freely
mobile liquid, calculated from the cerebrospinal ﬂuid of the subject. Anatomical reference images can be loaded in the right side panel to aid
segmentation.
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Figure 2. (A) Example of a MRI coronal roadmap image. Regions of interest are drawn on the segments of the colon that are visible on this image
plane. (B) Three-dimensional reconstruction of the colon of this subject. The ascending colon is rendered in red, the transverse colon in green, and
the descending colon in yellow. (C) Highly T2 weighted image from a plane approximately corresponding to (A). In this MRI sequence freely
mobile liquid appears white and most of the other tissues and poorly mobile or bound liquid appear dark. (D) Maximum intensity projection (MIP)
image of all the freely mobile liquid pockets in the colon after thresholding. The colon outline is sketched for anatomical reference using a dashed
orange line. In the MIP shown for this subject, 60 min after ingesting the 240 mL water dose, 25 small water pockets were located for a total colon
freely mobile liquid volume of 11.1 mL. The liquid pockets were all located in the ascending colon and no water pocket was found in the transverse
and descending colon.
Figure 3. (A) Individual time course of the volume of freely mobile liquid in the colon. Average time course (mean ± SEM) of the volume of freely
mobile liquid in the colon. The data are from n = 12 fasting healthy volunteers who ingested a 240 mL (∼8 ounces) drink of water.
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total volume of 2 ± 1 mL. The colonic ﬂuid peaked 30 min
after the water drink to 7 ± 4 mL (Figure 3B) and declined
toward 3−4 mL mean 60 min after the drink. The individual
variability was very high, with subjects having freely mobile ﬂuid
volume ranging from 0 to 49 mL (Figure 3A). A volume peak is
often seen after the drink but its timing varies greatly too.
Figure S1 in Supporting Information shows the diﬀerent order
of magnitude of freely mobile liquid volumes in stomach, small
bowel (using the data from the previous publication), and
colon.
Number of Freely Mobile Colon Liquid Pockets as a
Function of Time. The individual numbers of colon freely
mobile liquid pockets as a function of time are shown in Figure
4A and the corresponding mean data in Figure 4B. The fasted
colon contained 11 ± 5 pockets of resting liquid. The number
of pockets peaked in a similar fashion and timing to the colonic
liquid volume, around 30 min after the drink at 17 ± 7 separate
liquid pockets. After a short dip, the number of pockets
increases again to 17 pockets around 60 min after the drink.
The interindividual variability was very high, with subjects
showing a range of number of colonic ﬂuid pockets from 0 to
89.
Size of Colon Liquid Pockets as a Function of Time.
The size (volume) of freely mobile liquid pockets in the colon
as a function of time are shown for each individual in Figure 5A.
The corresponding mean data as a function of time are shown
in Figure 5B. A breakdown by bin size shows that the majority
of freely mobile water pockets in the colon are small (Figure
5C).
Regional Analyses of Colon Water Pocket Volumes
and Numbers. The regional analysis of liquid volumes showed
that the colonic liquid volume was found primarily in the
ascending colon (Figure 6). The same applies to the regional
analysis by number of liquid pockets which is dominated by the
ascending colon. The individual data for the ascending colon
(Figure 7A) and the regional means (Figure 7B) are shown.
Correlation Analyses. Having obtained the colon liquid
volume data, we performed exploratory post hoc analyses, at an
individual level, to assess if changes in colon water would
correlate with changes in small bowel liquid volume as the data
for the latter are available from our previous study. In Figure 8
the peak colon liquid volume for each participant is plotted
against the corresponding lower left quadrant (mostly ileal)
small bowel liquid volume at the same time point. There was a
positive and signiﬁcant correlation between peak colon liquid
volumes and lower left (ileal) small bowel liquid volumes (r =
0.78, p = 0.0030).
■ DISCUSSION
This initial study achieved its aims and the data conﬁrmed our
prediction. MRI provided unprecedented insights on the fasting
time course, number, and volume of liquid pockets in the
undisturbed human colon under conditions that represent
standard BA/BE studies. The baseline, fasting colon contained
only a few milliliters of freely mobile water, distributed in small
pockets. Thirty minutes after ingestion of the 240 mL water
drink an inﬂux of ﬂuid increased the number and size of the
colonic liquid pockets; these diﬀerences were not signiﬁcant,
possibly due to large variability. One hour after the drink, the
colonic liquid pockets size returned to the small baseline size
but in higher numbers and total volume. The water pockets are
primarily very small, Figure 5C shows that most are <0.5 mL
size. The regional analysis showed that the colonic liquid
pockets were located primarily in the ascending colon region
only.
In some subjects we observed a rise in the mean total volume
of liquid shortly after the drink was ingested. This could reﬂect
gastro-colonic reﬂex, moving ileal residue into the colon.
However, it could also represent the arrival of the “head of the
drink” in the colon whereby initial aliquots of the ingested
liquid can exit the stomach before any feedback signaling can be
established and travel quickly the length of the small bowel.
Breath test studies can indeed show a rise in the signal from the
colonic label shortly after ingestion.
In Shiller’s study,8 the colon ﬂuid volumes in the fasted state
were similarly variable from 1 to 44 mL and the ﬂuid pockets
were detected mainly in the cecum, the ascending and the
descending colon. On the other hand, in the fed state the colon
ﬂuid volumes ranged from 2 to 97 mL and there was a
signiﬁcant increase in the number of ﬂuid pockets, although the
Figure 4. (A) Individual time course of the number of freely mobile liquid pockets in the colon. (B) Average time course (mean ± SEM) of the
number of the freely mobile liquid pockets in the colon. The data are from n = 12 fasting healthy volunteers who ingested a 240 mL (∼8 ounces)
drink of water.
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Figure 5. (A) Individual time course of the number of freely mobile liquid pockets in the colon. (B) Average time course (mean ± SEM) of the
number of the freely mobile liquid pockets in the colon. (C) Average time course (mean ± SEM) of the number of freely mobile liquid pockets in
the colon sorted into 6 diﬀerent bin sizes (i.e., bands). The data are from n = 12 fasting healthy volunteers who ingested a 240 mL (∼8 ounces) drink
of water.
Figure 6. Individual time course of the volume of freely mobile liquid in (A) the ascending colon. (B) Average time course (mean ± SEM) of the
number of the freely mobile liquid pockets in the colon sorted by region for the ascending, transverse, and descending colon. The data are from n =
12 fasting healthy volunteers who ingested a 240 mL (∼8 ounces) drink of water.
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ﬂuid volume per pockets was not signiﬁcantly changed
(median: fasting 2 mL and fed 1 mL).
Here we referred to the regions of freely mobile ﬂuid in the
colon as “pockets” in keeping with previous literature. It is
worth noting that the concept of pockets (or packets) of ﬂuid
exiting the stomach and populating the small bowel is easier to
picture than within the colon environment, where contractility
does not tend to create the small isolated spaces one would
associate with a pocket. In the colon the pockets represent
more regions of freely mobile water within the chyme and their
boundaries are susceptible to changes depending on the
threshold calculated by the software in relation to the
cerebrospinal ﬂuid.
This study had some limitations. The subjects were studied
for only 2 h while modiﬁed release formulations act for a much
longer time, hence future studies should image the colon for
longer than 2 h. The MRI quantiﬁcation method has been
validated using naso-duodenal intubations.19 The validation
work consisted in intubating healthy volunteers naso-
duodenally and instilling rapidly known volume boluses of
poorly absorbable ﬂuid. A complete abdominal image data set
was acquired immediately after each bolus was instilled in the
bowel therefore allowing calibration of the signal distribution
versus the infused volumes. While the translation of such
methods to the colon is straightforward, it should be noted that
the quantiﬁcation of liquid volumes in mL in the colon has not
yet been directly validated. The imaging voxels that contain
some freely mobile water and some gas/tissue/more solid
component suﬀer from partial volume eﬀects and may be
excluded by the calculated liquid intensity threshold. As a result,
the total amount of freely mobile water may be slightly
underestimated. The MRI method used here has a long echo
time TE and strong T2 weighting hence images only the
hydrogen protons of freely mobile, high tumbling, long
relaxation time water molecules. The signal from less mobile,
more viscous fractions, such as mucous or unstirred layers
adjacent to the mucosa, will have decayed and therefore are not
captured. Another parameter that was not investigated is
intrasubject variability, a further test-retest study is needed.
There are indeed other MRI methods that can provide
information on the water environment of the colon chyme. We
have used the longitudinal relaxation time T1 following dosing
with oral polyethylene glycol20 and the transverse relaxation
time T2 following a mannitol model of diarrhea and dosing
with loperamide,9 both can be informative but do not
quantitate volumes. Quantitative magnetization transfer ratio
is another method but the magnetization transfer dependence
on the physicochemical environment such as chemical
exchange, presence of macromolecules, dipolar interactions
and water diﬀusion is very complex and quantifying volumes
from this diﬃcult.
Our study is also ﬁrst in trying to correlate the amounts of
water in the small bowel and in the colon. This was an
exploratory post hoc analysis. It was somehow diﬃcult to predict
the direction of the correlation, if any. Larger amounts of water
in the small bowel could allow larger transfers to the colon
hence higher volumes of colonic water. On the other hand,
increased motility could reduce the amount of water in the
small bowel and increase it in the colon as seen for example in
patients with irritable bowel syndrome with diarrhea (IBS-
D).21,22 We found here a positive and signiﬁcant correlation
between peak colon liquid volumes and distal (lower right
quadrant) bowel liquid volume at corresponding time points.
This study was not initially aimed or powered to look at such
Figure 7. (A) Individual time course of the number of freely mobile liquid in the ascending colon. (B) Average time course (mean ± SEM) of the
number of the freely mobile liquid pockets in the colon sorted by region for the ascending, transverse and descending colon. The data are from n =
12 fasting healthy volunteers who ingested a 240 mL (∼8 ounces) drink of water.
Figure 8. Plot of peak colon liquid volume for each participant against
the corresponding lower left quadrant (mostly ileal) small bowel liquid
volume taken from ref 18. The data are from n = 12 fasting healthy
volunteers who ingested a 240 mL (∼8 ounces) drink of water.
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correlations hence caution in interpreting them is needed.
These preliminary ﬁndings require further investigation.
The colon is critical for release and subsequent absorption of
controlled release formulations designed to release their drug
contents between 6 and 24 h. Solubility and dissolution have
been suggested to be more restricted in the colon than in the
upper small intestine due to several factors, lower water content
being one of them.23 Tannergren and co-workers collected
regional absorption data of 42 drugs and obtained or calculated
the relative bioavailability after administration directly to the
colon compared to after oral dosing (abbreviated as Frelcolon).
They found the majority of BCS I drugs (high solubility and
high permeability) administered as solutions, granules, or
suspensions to be well absorbed in the colon, with a measured
or calculated Frelcolon > 70%. It can be inferred that the amount
of total water, whether it be freely mobile or entrapped in
colonic chyme/biomass, was enough to maintain an adequate
amount of dissolved drug to be transported to the intestinal
wall via the convective transport responsible for water
reabsorption as well as likely via diﬀusive transport for these
high solubility compounds. In the same study, it was
documented that some BCS II drugs (low solubility and high
permeability) administered to the colon as solutions had lower
absorption than would be expected if one assumed the entire
dose of drug remained in solution in the colon. This result
could have been due to potential precipitation in the colon as a
result of low water content.
While it is reasonable to infer that both entrapped and freely
mobile water would have the ability to maintain a drug in
solution provided a high enough drug solubility, the question of
at what rate and to what extent drug solids could dissolve in
entrapped water and be transported to the colonic mucosal
membrane is less straightforward to answer due to a lack of
direct measurements. It is likely that dissolution and transport
of drug particles is slowed in the presence of biomass compared
to in freely mobile water as a result of multiple factors. For
example, a decreased extent of stirring in the colonic lumen due
to obstruction from solid materials would be expected to
decrease ﬂux from the solid particle surface for particles above a
diameter of approximately 20 μm.24 In addition, increased
tortuosity/viscosity in the presence of biomass likely hinders
diﬀusive and convective transport of solid particles from the
colonic lumen to the colonic mucosa. While the data set of
Tannergren and co-workers was insuﬃcient to assess the
impact of low solubility and slow dissolution rate on colonic
absorption, it was shown that for two compounds administered
to the colon both as solutions and suspensions, Cmax was
diminished for the suspension compared to the solution. The
documented dose/solubility ratio was 213 mL for one
compound (“AZ6”) and 375 mL for the other (Dexloxiglu-
mide). Assuming the documented solubility reﬂected the
solubility in the human colonic ﬂuid, an average entrapped
water content of 482 mL (i.e., higher than the dose/solubility
ratio) would be needed to dissolve these compounds such that
Cmax matched that of the solution, if the volume of entrapped
versus freely mobile water were the more relevant parameter to
consider.
Recently Georgaka and co-workers25 conducted a study
designed to evaluate the impact of “solid particles” contained
within dissolution medium designed to simulate properties and
composition in the fasted ascending colon (FaSSCoF). To
simulate solids they added microcrystalline cellulose spheres to
the medium and compared dissolution results in the same
medium in the absence of solid particles. In the ﬁrst stage of the
2-stage dissolution test, the dosage form was placed in a mini
dissolution vessel ﬁlled with 40 mL of medium representative of
the distal ileum (no solid particles) and stirred for 2 h (Stage
1). A second solution was then added to the vessel to achieve
∼200 mL of FaSSCoF with or without microcrystalline
cellulose spheres and stirred for an additional 160 min (Stage
2). To ensure reproducible sampling in the presence of solid
particles, contents were stirred along the length of the mini
dissolution vessel at 100 rpm using an in-house paddle system
consisting of ﬁve blades distributed along a shaft. For
experiments conducted in the absence of solid particles, a
Distek (Distek, Inc., New Brunswick, NJ) single blade, mini
paddle stirred at 75 rpm (ileal portion, Stage 1) and 40 rpm
(colonic portion, Stage 2) was used. Results demonstrated
nearly identical concentration−time proﬁles in FaSSCoF during
the colonic portion of the test in the presence and absence of
solid particles for sulfasalazine (Azulﬁdine 500 mg immediate
release tablet) and mesalamine (Asacol 400 mg colon targeting
tablet). These results demonstrate that the simple presence of
solid material in the fasted simulated ﬂuids coupled with
potential diﬀerences in hydrodynamics between the two
paddles and stirring speeds did not alter apparent drug
concentration versus time proﬁles for these two dosage
forms. The paddle stirring mechanism used in Stage 2 of the
in vitro test is diﬀerent from colonic stirring in vivo. For
example, in vitro, the paddle blades are positioned within the
bed of solid particles, which presumably results in some radial
as well as axial movement within the mini dissolution vessel. In
vivo, the colon contents move mainly axially along the length of
the intestine with a central channel of increased displacement
with reduced ﬂow near the walls of the colon, probably
impeded by the haustra.26 Due to these diﬀerences in stirring, it
is diﬃcult to judge how accurately the in vitro test set up used
by Georgaka and co-workers can assess the impact of actual in
vivo solid particles/biomass on the rate and extent of
dissolution of Azulﬁdine or Asacol tablets. For example, if the
particle size of disintegrated drug particles of sulfasalazine
administered as Azulﬁdine (immediate release) and/or mesal-
amine administered as Asacol (pH-triggered release via a
coating designed to dissolve at pH > 7) are > ∼ 20 μm, then
rate of stirring (e.g., shear and convection) could aﬀect
dissolution rate. If, however, drug particles are mostly <20
μm, then stirring may not signiﬁcantly aﬀect release. In
addition, the transport of solid drug particles to the colonic
mucosal membrane in vivo is likely inﬂuenced by the stirring
rate/mechanism of solid particles/biomass in vivo, which was
not a factor studied in the in vitro test.
Taken together with knowledge of the entrapped water
content and physicochemical properties of colonic ﬂuid, the
time course of freely mobile liquid volumes in the colon has
signiﬁcant implications for designing and predicting the oral
bioperformance of solid dosage forms, particularly those with
low aqueous solubility (e.g., BCS II or IV) in small intestine
and/or colon, and which may be in the form of relatively large
solid particles upon entry to the colon. Intestinal water volume
can signiﬁcantly aﬀect dosage form release, dissolution, and
absorption kinetics and therefore the rate of appearance of
compounds in the bloodstream. The information regarding
total liquid volume in the colon and distribution into individual
pockets as determined in this study can be used to inform in
vitro biopredictive dissolution tests. It can also be used as a
starting point for the development of novel computational
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models describing transport and distribution of liquid as well as
drug release and dissolution throughout the gastrointestinal
tract.
■ CONCLUSION
This study is the ﬁrst to quantify the time course of volume and
distribution of freely mobile water in the colon under
conditions representing BA/BE studies using MRI method-
ology. The information collected will have important
implications for the rates and extents of dosage form release,
dissolution, precipitation, and absorption when present in the
human colon, and can be used to develop biorelevant
dissolution methodologies, as well as mechanistic computa-
tional transport analyses for oral bioperformance prediction.
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